ArticleJournal of gastroenterology2026

Comment on "Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel disease": treatment comparison or treatment sequencing?

Xichen Fan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.